Mostrar el registro sencillo del ítem

Bacteriophages in the control of pathogenic vibrios

dc.contributor.authorPlaza N.
dc.contributor.authorCastillo D.
dc.contributor.authorPérez-Reytor D.
dc.contributor.authorHiguera G.
dc.contributor.authorGarcía K.
dc.contributor.authorBastías R.
dc.date.accessioned2020-09-02T22:25:52Z
dc.date.available2020-09-02T22:25:52Z
dc.date.issued2018
dc.identifier10.1016/j.ejbt.2017.10.012
dc.identifier.citation31, , 24-33
dc.identifier.issn07173458
dc.identifier.urihttps://hdl.handle.net/20.500.12728/5816
dc.descriptionVibrios are common inhabitants of marine and estuarine environments. Some of them can be pathogenic to humans and/or marine animals using a broad repertory of virulence factors. Lately, several reports have indicated that the incidence of Vibrio infections in humans is rising and also in animals constitute a continuing threat for aquaculture. Moreover, the continuous use of antibiotics has been accompanied by an emergence of antibiotic resistance in Vibrio species, implying a necessity for efficient treatments. One promising alternative that emerges is the use of lytic bacteriophages; however, there are some drawbacks that should be overcome to make phage therapy a widely accepted method. In this work, we discuss about the major pathogenic Vibrio species and the progress, benefits and disadvantages that have been detected during the experimental use of bacteriophages to their control. © 2017
dc.language.isoen
dc.publisherPontificia Universidad Catolica de Valparaiso
dc.subjectAntibiotic
dc.subjectCholera
dc.subjectGram-negative bacteria
dc.subjectPhage therapy
dc.subjectVibrio
dc.subjectVibrio anguillarum
dc.subjectVibrio cholerae
dc.subjectVibrio harveyi
dc.subjectVibrio parahaemolyticus
dc.subjectVirulence
dc.subjectAnimals
dc.subjectAntibiotics
dc.subjectBacteria
dc.subjectCholera
dc.subjectGram-negative bacteria
dc.subjectPhage therapy
dc.subjectVibrio
dc.subjectVibrio anguillarum
dc.subjectVibrio cholerae
dc.subjectVibrio harveyi
dc.subjectVibrio parahaemolyticus
dc.subjectVirulence
dc.subjectBacteriophages
dc.subjectampicillin
dc.subjectazithromycin
dc.subjectcarbenicillin
dc.subjectcefalotin
dc.subjectchloramphenicol
dc.subjectciprofloxacin
dc.subjectcotrimazine
dc.subjecterythromycin
dc.subjecthemolysin
dc.subjectkanamycin
dc.subjectpenicillin G
dc.subjectpolymyxin B
dc.subjectquinoline derived antiinfective agent
dc.subjectstreptomycin
dc.subjectsulfamethoxazole
dc.subjecttetracycline
dc.subjectantibiotic resistance
dc.subjectbacterial strain
dc.subjectbacterial virulence
dc.subjectbacteriophage
dc.subjectbacterium isolate
dc.subjectcell motility
dc.subjectCRISPR Cas system
dc.subjectcytotoxicity
dc.subjectdiarrhea
dc.subjecthuman
dc.subjectListeria monocytogenes
dc.subjectnonhuman
dc.subjectPhotobacterium damselae
dc.subjectprotein expression
dc.subjectReview
dc.subjectVibrio
dc.subjectVibrio aestuarianus
dc.subjectVibrio alginolyticus
dc.subjectVibrio anguillarum
dc.subjectVibrio campbellii
dc.subjectVibrio cholerae
dc.subjectVibrio cincinnatiensis
dc.subjectVibrio fluvialis
dc.subjectVibrio furnisii
dc.subjectVibrio harveyi
dc.subjectVibrio metschnikovii
dc.subjectVibrio mimicus
dc.subjectVibrio ordalli
dc.subjectVibrio owensii
dc.subjectVibrio parahaemolyticus
dc.subjectVibrio splendidus
dc.subjectVibrio vulnificus
dc.titleBacteriophages in the control of pathogenic vibrios
dc.typeReview


Ficheros en el ítem

Thumbnail
Nombre:
item_2-s2.0-85040097110.pdf
Tamaño:
3.763Kb
Formato:
PDF
Ver/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem